Intravenous Infusions (XGHA:IIL) EV-to-EBITDA : (As of Jun. 19, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Intravenous Infusions's enterprise value is GHS0.00 Mil. Intravenous Infusions does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Intravenous Infusions's EV-to-EBITDA at this moment.

The historical rank and industry rank for Intravenous Infusions's EV-to-EBITDA or its related term are showing as below:

XGHA:IIL's EV-to-EBITDA is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 14.355
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-19), Intravenous Infusions's stock price is GHS0.05. Intravenous Infusions does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Intravenous Infusions's PE Ratio at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Intravenous Infusions EV-to-EBITDA Historical Data

The historical data trend for Intravenous Infusions's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions EV-to-EBITDA Chart

Intravenous Infusions Annual Data

Trend

EV-to-EBITDA

Intravenous Infusions Semi-Annual Data

EV-to-EBITDA

Competitive Comparison of Intravenous Infusions's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Intravenous Infusions's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intravenous Infusions's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intravenous Infusions's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Intravenous Infusions's EV-to-EBITDA falls into.

Intravenous Infusions EV-to-EBITDA Calculation

Intravenous Infusions's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	0.000	/
	=

Intravenous Infusions (XGHA:IIL) EV-to-EBITDA Explanation

Intravenous Infusions's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	0.05	/
	=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Intravenous Infusions EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Intravenous Infusions (XGHA:IIL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA

Website

https://www.iil.com.gh

Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.